EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The application of telmisartan in central nervous system disorders

Wei Quan, Shui-Xian Zhang, Xu-Yang Zhang, Xi Chen, Chao Yang, Zhi-Yu Li, Rong Hu

Pharmacological Reports · 2025

DOI: 10.1007/s43440-025-00737-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmacological Reports, 2025. Verfasst von Wei Quan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Telmisartan, Central Nervous System Diseases, Angiotensin II Type 1 Receptor Blockers, Neuroprotective Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 255 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Telmisartan, a well-established antihypertensive drug, has shown promising therapeutic potential for a variety of central nervous system (CNS) disorders. This review outlines the fundamental characteristics of telmisartan, focusing on its dual pharmacological effects as an angiotensin II type 1 receptor (AT1R) antagonist and a peroxisome proliferator-activated receptor (PPAR) γ activator. These mechanisms underpin its neuroprotective and anti-inflammatory effects, which are essential to its therapeutic benefits in CNS diseases. Telmisartan modulates key cellular components of the CNS, including microglia, astrocytes, oligodendrocytes, vascular endothelial cells, and neurons, thereby offering protection against neuroinflammation, oxidative stress, and neuronal damage. We summarize telmisartan's efficacy in addressing a range of neurological conditions, such as stroke, traumatic brain injury, dementia, Parkinson's disease, demyelinating diseases, psychiatric disorders, and gliomas. By targeting multiple pathways involved in these disorders, telmisartan demonstrates potential as both an adjunctive and standalone therapy. Its ability to attenuate neuroinflammation and promote cellular repair highlights its versatility in CNS disease management. This review underscores the potential of telmisartan as a valuable therapeutic option for CNS disorders, warranting continued exploration to optimize its clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TelmisartanCentral Nervous System DiseasesAngiotensin II Type 1 Receptor BlockersNeuroprotective AgentsHumansAnimalsPPAR gamma

Stichwörter der Autor:innen

AT1RCentral nervous systemNeuroinflammationPPARγTelmisartan

Substanzen

TelmisartanAngiotensin II Type 1 Receptor BlockersNeuroprotective AgentsPPAR gamma

Autor:innen und Institutionen

  • Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China.
  • Department of Neurosurgery, Zhongnan Hospital, Wuhan University, Hubei, China.
  • Department of Neurosurgery, Southwest Hospital, Third Military Medical University, Chongqing, China. huchrong@tmmu.edu.cn.

Zitieren

APA

Quan, W., Zhang, S. X., Zhang, X. Y., Chen, X., Yang, C., Li, Z. Y., & Hu, R. (2025). The application of telmisartan in central nervous system disorders. Pharmacological Reports. https://doi.org/10.1007/s43440-025-00737-2

Vancouver

Quan W, Zhang SX, Zhang XY, Chen X, Yang C, Li ZY, et al. The application of telmisartan in central nervous system disorders. Pharmacological Reports. 2025. doi:10.1007/s43440-025-00737-2

BibTeX
@article{Quan2025,
  author = {Quan, Wei and Zhang, Shui-Xian and Zhang, Xu-Yang and Chen, Xi and Yang, Chao and Li, Zhi-Yu and Hu, Rong},
  title = {The application of telmisartan in central nervous system disorders},
  journal = {Pharmacological Reports},
  year = {2025},
  doi = {10.1007/s43440-025-00737-2}
}
Kostenlos starten →